Ballwin, MO, United States of America

Charles A McWherter

This inventor holds 1 USPTO granted patent. Top assignee: Monsanto Company. Active years: 1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Charles A McWherter. Retrieved from https://idiyas.com/inventor/charles-a-mcwherter-ywzuahas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 30(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Charles A McWherter: Innovator in Serine Protease Inhibition

Introduction

Charles A McWherter is a notable inventor based in Ballwin, MO (US). He has made significant contributions to the field of biochemistry, particularly in the area of serine protease inhibitors. His work has implications for treating various medical conditions caused by unwanted serine protease activity.

Latest Patents

McWherter holds a patent for synthetic polypeptides that exhibit potent serine protease inhibition. This patent outlines methods and compositions that are useful for treating conditions associated with unwanted serine protease activity. His innovative approach has the potential to advance therapeutic options in this area.

Career Highlights

Throughout his career, McWherter has been associated with Monsanto Company, where he has applied his expertise in biochemistry to develop impactful solutions. His work at Monsanto has allowed him to collaborate with other leading scientists in the field.

Collaborations

One of his notable coworkers is George I Glover, with whom he has likely shared insights and expertise in their research endeavors.

Conclusion

Charles A McWherter's contributions to the field of serine protease inhibition highlight his role as an innovator in biochemistry. His patent and work at Monsanto Company reflect his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…